Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.530
-0.010 (-0.65%)
At close: Nov 4, 2024, 4:00 PM
1.520
-0.010 (-0.68%)
After-hours: Nov 4, 2024, 6:22 PM EST

Quince Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Selling, General & Admin
1715.424.9129.5217.598.95
Upgrade
Research & Development
12.519.2525.1860.861.3130.21
Upgrade
Operating Expenses
29.5224.6450.0990.3278.8939.17
Upgrade
Operating Income
-29.52-24.64-50.09-90.32-78.89-39.17
Upgrade
Interest & Investment Income
3.683.481.070.622.042.19
Upgrade
Currency Exchange Gain (Loss)
00-0.77-0.25--
Upgrade
Other Non Operating Income (Expenses)
-1.24-0.34----
Upgrade
EBT Excluding Unusual Items
-27.07-21.5-49.79-89.95-76.85-36.98
Upgrade
Merger & Restructuring Charges
-2.5-2.5-1.1---
Upgrade
Impairment of Goodwill
-17.13--0.83---
Upgrade
Gain (Loss) on Sale of Assets
0.04-0.04-0.09---
Upgrade
Asset Writedown
--5.97-0.14---
Upgrade
Other Unusual Items
-6.34-1.58----
Upgrade
Pretax Income
-53.01-31.58-51.94-89.95-76.85-36.98
Upgrade
Income Tax Expense
0.12-0.2-0.28---
Upgrade
Net Income
-53.12-31.39-51.66-89.95-76.85-36.98
Upgrade
Net Income to Common
-53.12-31.39-51.66-89.95-76.85-36.98
Upgrade
Shares Outstanding (Basic)
413733302919
Upgrade
Shares Outstanding (Diluted)
413733302919
Upgrade
Shares Change (YoY)
14.07%11.17%12.71%1.86%53.30%466.06%
Upgrade
EPS (Basic)
-1.30-0.84-1.54-3.03-2.63-1.94
Upgrade
EPS (Diluted)
-1.30-0.84-1.54-3.03-2.63-1.94
Upgrade
Free Cash Flow
-28.09-18.45-44.17-63.11-50.87-33.33
Upgrade
Free Cash Flow Per Share
-0.69-0.50-1.32-2.12-1.74-1.75
Upgrade
EBITDA
-29.13-24.32-49.89-89.97-78.56-38.98
Upgrade
D&A For EBITDA
0.390.320.20.340.330.19
Upgrade
EBIT
-29.52-24.64-50.09-90.32-78.89-39.17
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.